V

Vor Biopharma
D

VOR

22.375
USD
-0.87
(-3.72%)
مفتوح الان
حجم التداول
22,323
الربح لكل سهم
-8
العائد الربحي
-
P/E
0
حجم السوق
1,323,756,328
المقالات
المزيد

العنوان: Vor Biopharma Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.